BSX : Post-market Study Data Reinforce Success & Safety Of ACURATE Neo2 Aortic Valve System
(RTTNews) - Boston Scientific Corp. (BSX) said that post-market study data reinforced clinical procedural success and safety of the ACURATE neo2 Aortic Valve System.
The ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluated the performance of the ACURATE neo2TM Aortic Valve System. The findings showed a high procedural success......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Monday, 28 November
The ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluated the performance of the ACURATE neo2TM Aortic Valve System. The findings showed a high procedural success......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Monday, 28 November
- Older News
- Bericht: Half-Life 3 2015 verschrottet, Valve-Insider leckt Gameplay und Story - Gamereactor Deutschland Google News - International.. (Today) - Bericht: Half-Life 3 2015 verschrottet, Valve-Insider leckt Gameplay und Story Gamereactor Deutschland...
- EQS-News: Aflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study Finanzen.at - Nachrichten Ticker (Today) - EQS-News: Formycon AG/ Key word(s): Study results/StudyAflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study 06.02.2023 / 07:30 CET/CESTThe issuer is...